Amneal Pharmaceuticals Inc
NYSE:AMRX
Income Statement
Earnings Waterfall
Amneal Pharmaceuticals Inc
Revenue
|
2.4B
USD
|
Cost of Revenue
|
-1.5B
USD
|
Gross Profit
|
856.7m
USD
|
Operating Expenses
|
-581.8m
USD
|
Operating Income
|
274.8m
USD
|
Other Expenses
|
-358.8m
USD
|
Net Income
|
-84m
USD
|
Income Statement
Amneal Pharmaceuticals Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
511
N/A
|
482
-6%
|
540
+12%
|
566
+5%
|
596
+5%
|
620
+4%
|
647
+4%
|
710
+10%
|
861
+21%
|
943
+10%
|
901
-4%
|
908
+1%
|
824
-9%
|
783
-5%
|
813
+4%
|
791
-3%
|
776
-2%
|
867
+12%
|
1 078
+24%
|
1 348
+25%
|
1 663
+23%
|
1 834
+10%
|
1 825
-1%
|
1 727
-5%
|
1 626
-6%
|
1 679
+3%
|
1 739
+4%
|
1 880
+8%
|
1 993
+6%
|
1 987
0%
|
2 057
+4%
|
2 067
+0%
|
2 094
+1%
|
2 098
+0%
|
2 122
+1%
|
2 139
+1%
|
2 212
+3%
|
2 272
+3%
|
2 312
+2%
|
2 386
+3%
|
2 394
+0%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(299)
|
(267)
|
(274)
|
(277)
|
(281)
|
(306)
|
(357)
|
(411)
|
(501)
|
(540)
|
(510)
|
(776)
|
(976)
|
(1 012)
|
(1 042)
|
(821)
|
(632)
|
(603)
|
(709)
|
(805)
|
(938)
|
(1 117)
|
(1 178)
|
(1 177)
|
(1 147)
|
(1 151)
|
(1 174)
|
(1 260)
|
(1 330)
|
(1 318)
|
(1 320)
|
(1 296)
|
(1 302)
|
(1 324)
|
(1 355)
|
(1 376)
|
(1 416)
|
(1 473)
|
(1 498)
|
(1 535)
|
(1 537)
|
|
Gross Profit |
213
N/A
|
215
+1%
|
266
+24%
|
289
+9%
|
316
+9%
|
314
0%
|
289
-8%
|
298
+3%
|
360
+21%
|
403
+12%
|
391
-3%
|
132
-66%
|
(151)
N/A
|
(229)
-51%
|
(229)
0%
|
(30)
+87%
|
144
N/A
|
264
+83%
|
369
+40%
|
543
+47%
|
725
+34%
|
717
-1%
|
647
-10%
|
550
-15%
|
479
-13%
|
528
+10%
|
565
+7%
|
620
+10%
|
663
+7%
|
670
+1%
|
737
+10%
|
770
+5%
|
792
+3%
|
775
-2%
|
768
-1%
|
764
-1%
|
796
+4%
|
799
+0%
|
814
+2%
|
851
+5%
|
857
+1%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(188)
|
(186)
|
(192)
|
(206)
|
(219)
|
(236)
|
(248)
|
(255)
|
(272)
|
(276)
|
(278)
|
(288)
|
(282)
|
(290)
|
(301)
|
(295)
|
(297)
|
(270)
|
(299)
|
(355)
|
(441)
|
(509)
|
(519)
|
(499)
|
(492)
|
(465)
|
(477)
|
(503)
|
(517)
|
(544)
|
(555)
|
(567)
|
(575)
|
(585)
|
(594)
|
(600)
|
(597)
|
(588)
|
(577)
|
(586)
|
(582)
|
|
Selling, General & Administrative |
(120)
|
(116)
|
(116)
|
(127)
|
(139)
|
(164)
|
(180)
|
(187)
|
(201)
|
(195)
|
(192)
|
(201)
|
(202)
|
(205)
|
(211)
|
(210)
|
(216)
|
(199)
|
(204)
|
(233)
|
(247)
|
(306)
|
(318)
|
(302)
|
(304)
|
(295)
|
(309)
|
(328)
|
(337)
|
(353)
|
(356)
|
(363)
|
(373)
|
(378)
|
(390)
|
(399)
|
(404)
|
(408)
|
(415)
|
(428)
|
(434)
|
|
Research & Development |
(68)
|
(70)
|
(76)
|
(80)
|
(79)
|
(72)
|
(68)
|
(68)
|
(71)
|
(81)
|
(86)
|
(87)
|
(81)
|
(85)
|
(90)
|
(86)
|
(81)
|
(103)
|
(126)
|
(153)
|
(194)
|
(203)
|
(201)
|
(197)
|
(188)
|
(171)
|
(168)
|
(175)
|
(180)
|
(192)
|
(199)
|
(203)
|
(202)
|
(206)
|
(204)
|
(206)
|
(196)
|
(182)
|
(169)
|
(160)
|
(164)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
31
|
31
|
31
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
1
|
4
|
3
|
2
|
7
|
1
|
16
|
|
Operating Income |
24
N/A
|
29
+19%
|
75
+157%
|
83
+11%
|
97
+17%
|
78
-20%
|
42
-46%
|
44
+5%
|
88
+100%
|
127
+44%
|
114
-10%
|
(156)
N/A
|
(433)
-178%
|
(518)
-20%
|
(531)
-2%
|
(325)
+39%
|
(153)
+53%
|
(7)
+96%
|
70
N/A
|
189
+169%
|
285
+51%
|
209
-27%
|
128
-39%
|
51
-60%
|
(13)
N/A
|
63
N/A
|
87
+39%
|
117
+34%
|
146
+24%
|
125
-14%
|
183
+46%
|
203
+11%
|
216
+6%
|
189
-12%
|
174
-8%
|
163
-6%
|
199
+22%
|
212
+6%
|
237
+12%
|
265
+12%
|
275
+4%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
1
|
1
|
1
|
1
|
1
|
(3)
|
(10)
|
(22)
|
(39)
|
(44)
|
(45)
|
(44)
|
(40)
|
(46)
|
(52)
|
(60)
|
(22)
|
(53)
|
(101)
|
(130)
|
(163)
|
(200)
|
(173)
|
(179)
|
(173)
|
(170)
|
(167)
|
(138)
|
(130)
|
(116)
|
(119)
|
(129)
|
(137)
|
(140)
|
(145)
|
(158)
|
(171)
|
(183)
|
(192)
|
(198)
|
(209)
|
|
Non-Reccuring Items |
(31)
|
(31)
|
(29)
|
(12)
|
(8)
|
(4)
|
(21)
|
(21)
|
(35)
|
(29)
|
(13)
|
(44)
|
(61)
|
(67)
|
(68)
|
(39)
|
(282)
|
(280)
|
(549)
|
(558)
|
(327)
|
(400)
|
(140)
|
(54)
|
(36)
|
32
|
39
|
(69)
|
(54)
|
(46)
|
(47)
|
(42)
|
(64)
|
(59)
|
(310)
|
(283)
|
(294)
|
(295)
|
(42)
|
(39)
|
(70)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
46
|
46
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
17
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
153
|
3
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
(2)
|
(3)
|
(49)
|
(42)
|
4
|
7
|
8
|
(11)
|
9
|
7
|
0
|
3
|
3
|
2
|
4
|
2
|
1
|
1
|
2
|
3
|
3
|
6
|
9
|
15
|
17
|
20
|
21
|
18
|
19
|
12
|
7
|
(36)
|
|
Pre-Tax Income |
147
N/A
|
2
-99%
|
47
+2 522%
|
73
+55%
|
91
+24%
|
71
-21%
|
12
-83%
|
48
+285%
|
59
+24%
|
53
-11%
|
53
+1%
|
(292)
N/A
|
(576)
-97%
|
(626)
-9%
|
(643)
-3%
|
(412)
+36%
|
(451)
-10%
|
(331)
+27%
|
(573)
-73%
|
(498)
+13%
|
(203)
+59%
|
(388)
-91%
|
(182)
+53%
|
(178)
+2%
|
(220)
-24%
|
(74)
+67%
|
(39)
+47%
|
(88)
-123%
|
(36)
+59%
|
(34)
+4%
|
22
N/A
|
42
+89%
|
31
-26%
|
7
-79%
|
(261)
N/A
|
(257)
+2%
|
(248)
+3%
|
(248)
+0%
|
15
N/A
|
36
+141%
|
(40)
N/A
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(46)
|
0
|
(16)
|
(26)
|
(33)
|
(27)
|
(5)
|
(20)
|
(20)
|
(18)
|
(19)
|
111
|
104
|
66
|
66
|
(36)
|
(19)
|
12
|
24
|
16
|
1
|
10
|
3
|
(381)
|
(383)
|
(394)
|
(402)
|
(12)
|
(6)
|
(4)
|
(5)
|
(9)
|
(11)
|
(7)
|
(12)
|
(13)
|
(7)
|
(11)
|
(3)
|
3
|
(8)
|
|
Income from Continuing Operations |
101
|
2
|
32
|
48
|
57
|
45
|
8
|
28
|
39
|
35
|
34
|
(181)
|
(472)
|
(560)
|
(578)
|
(448)
|
(470)
|
(320)
|
(549)
|
(482)
|
(202)
|
(378)
|
(178)
|
(559)
|
(604)
|
(467)
|
(441)
|
(99)
|
(41)
|
(38)
|
18
|
34
|
20
|
(1)
|
(273)
|
(269)
|
(255)
|
(258)
|
11
|
39
|
(49)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
32
|
21
|
33
|
110
|
112
|
221
|
242
|
158
|
137
|
51
|
23
|
21
|
(8)
|
(20)
|
(10)
|
3
|
140
|
137
|
125
|
124
|
(13)
|
(28)
|
(35)
|
|
Net Income (Common) |
101
N/A
|
2
-98%
|
32
+1 341%
|
48
+50%
|
57
+21%
|
45
-22%
|
8
-83%
|
28
+264%
|
39
+41%
|
35
-11%
|
34
-2%
|
(181)
N/A
|
(472)
-161%
|
(560)
-19%
|
(578)
-3%
|
(448)
+22%
|
(469)
-5%
|
(371)
+21%
|
(370)
+0%
|
(313)
+15%
|
(21)
+93%
|
(69)
-229%
|
(67)
+3%
|
(339)
-408%
|
(362)
-7%
|
(199)
+45%
|
(194)
+2%
|
62
N/A
|
91
+47%
|
(17)
N/A
|
9
N/A
|
14
+52%
|
11
-24%
|
2
-83%
|
(134)
N/A
|
(132)
+1%
|
(130)
+2%
|
(135)
-4%
|
(2)
+98%
|
10
N/A
|
(84)
N/A
|
|
EPS (Diluted) |
1.49
N/A
|
0.03
-98%
|
0.45
+1 400%
|
0.67
+49%
|
0.81
+21%
|
0.63
-22%
|
0.1
-84%
|
0.37
+270%
|
0.54
+46%
|
0.49
-9%
|
0.46
-6%
|
-2.54
N/A
|
-6.63
-161%
|
-7.83
-18%
|
-7.92
-1%
|
-6.22
+21%
|
-6.54
-5%
|
-2.92
+55%
|
-2.9
+1%
|
-2.44
+16%
|
-0.17
+93%
|
-0.54
-218%
|
-0.52
+4%
|
-2.6
-400%
|
-2.74
-5%
|
-1.34
+51%
|
-1.31
+2%
|
0.42
N/A
|
0.61
+45%
|
-0.12
N/A
|
0.06
N/A
|
0.09
+50%
|
0.07
-22%
|
0.01
-86%
|
-0.89
N/A
|
-0.87
+2%
|
-0.86
+1%
|
-0.89
-3%
|
-0.02
+98%
|
0.06
N/A
|
-0.48
N/A
|